Long-term Effectiveness of Dupilumab Up to 52 Weeks in Atopic Dermatitis in 253 Adult Patients

Overview

Journal Br J Dermatol

Publisher Oxford University Press

Specialty Dermatology

Date 2020 Sep 30

PMID 32998177

Citations 8

Authors

E Nettis

G Fabbrocini

M Ortoncelli

G Pellacani

G Argenziano

E Di Leo

C Patruno

L Stingeni

C Foti

F Rongioletti

L Macchia

S Tavecchio

M Napolitano

S Ribero

L Bonzano

G Calabrese

D Di Bona

S P Nistico

K Hansel

P Romita

V Piras

M Carbonara

A Detoraki

S M Ferrucci

Affiliations

Soon will be listed here.

Citing Articles

Combined Dupilumab and Allergen-Specific Immunotherapy in Severe Refractory Atopic Dermatitis.

Kim J, Boo J, Jang H, Jung Y, Kim J, Zhang K Allergy Asthma Immunol Res. 2024; 16(6):682-689.

PMID: 39622691 PMC: 11621481. DOI: 10.4168/aair.2024.16.6.682.

Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China.

Deng S, Wang H, Chen Q, Chen X, Song X, Chen S Arch Dermatol Res. 2024; 316(6):304.

PMID: 38819652 DOI: 10.1007/s00403-024-03029-6.

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis.

Dubini M, Benzecry V, Rivolta F, Sangalli A, Marzano A, Pravettoni V Front Allergy. 2023; 4:1223657.

PMID: 37753208 PMC: 10518613. DOI: 10.3389/falgy.2023.1223657.

A concept for integrated care pathways for atopic dermatitis-A GA LEN ADCARE initiative.

Zuberbier T, Abdul Latiff A, Aggelidis X, Augustin M, Balan R, Bangert C Clin Transl Allergy. 2023; 13(9):e12299.

PMID: 37746794 PMC: 10500634. DOI: 10.1002/clt2.12299.

Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis.

Imai Y, Kusakabe M, Nagai M, Yasuda K, Yamanishi K JID Innov. 2021; 1(1):100003.

PMID: 34909707 PMC: 8659712. DOI: 10.1016/j.xjidi.2021.100003.